According to a recent LinkedIn post from ABM Respiratory Care, the company is showcasing its BiWaze Clear and BiWaze Cough airway clearance devices at Medtrade 2026, highlighting use cases in both hospital and home care settings. The post emphasizes clinical themes such as oscillating lung expansion therapy, secretion mobilization, cough augmentation, and support across the continuum of care.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The post suggests that ABM Respiratory Care is positioning its BiWaze platform as a differentiated solution within the respiratory therapy and durable medical equipment market, which could help drive adoption among providers and payers. For investors, this visibility at a targeted industry conference may support lead generation, strengthen relationships with home medical equipment distributors, and potentially expand recurring revenue tied to chronic respiratory care populations.